ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibody-Drug Conjugation Service Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-24E13097
Home | Market Reports | Computers & Electronics| Software
Global Antibody Drug Conjugation Service Market Insights Forecast to 2029
BUY CHAPTERS

Global Antibody-Drug Conjugation Service Market Research Report 2025

Code: QYRE-Auto-24E13097
Report
May 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boc Sciences
Abzena
Creative-Biolabs
Merck KGaA
Piramal
Charles River
Syngene
Novasep
Seagen
WuXi XDC
Levena Biopharma

Antibody-Drug Conjugation Service Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antibody-Drug Conjugation Service Market

Antibody-Drug Conjugation Service Market

The global market for Antibody-Drug Conjugation Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antibody-Drug Conjugation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody-Drug Conjugation Service.
The Antibody-Drug Conjugation Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody-Drug Conjugation Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody-Drug Conjugation Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antibody-Drug Conjugation Service Market Report

Report Metric Details
Report Name Antibody-Drug Conjugation Service Market
CAGR 5%
Segment by Type
Segment by Application
  • Breast Cancer
  • Lymphoma
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BOC Sciences, Abzena, Creative Biolabs, WuXi XDC, Merck KGaA, Piramal, Charles River, Syngene, Novasep, Seagen, Levena Biopharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antibody-Drug Conjugation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antibody-Drug Conjugation Service Market report?

Ans: The main players in the Antibody-Drug Conjugation Service Market are BOC Sciences, Abzena, Creative Biolabs, WuXi XDC, Merck KGaA, Piramal, Charles River, Syngene, Novasep, Seagen, Levena Biopharma

What are the Application segmentation covered in the Antibody-Drug Conjugation Service Market report?

Ans: The Applications covered in the Antibody-Drug Conjugation Service Market report are Breast Cancer, Lymphoma, Other

What are the Type segmentation covered in the Antibody-Drug Conjugation Service Market report?

Ans: The Types covered in the Antibody-Drug Conjugation Service Market report are Antibody Services, Payload Services, Linker Services, Other

Recommended Reports

Antibody & Drug Conjugates

Drug Development Services

Clinic & Pharma Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody-Drug Conjugation Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibody Services
1.2.3 Payload Services
1.2.4 Linker Services
1.2.5 Other
1.3 Market by Application
1.3.1 Global Antibody-Drug Conjugation Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody-Drug Conjugation Service Market Perspective (2020-2031)
2.2 Global Antibody-Drug Conjugation Service Growth Trends by Region
2.2.1 Global Antibody-Drug Conjugation Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody-Drug Conjugation Service Historic Market Size by Region (2020-2025)
2.2.3 Antibody-Drug Conjugation Service Forecasted Market Size by Region (2026-2031)
2.3 Antibody-Drug Conjugation Service Market Dynamics
2.3.1 Antibody-Drug Conjugation Service Industry Trends
2.3.2 Antibody-Drug Conjugation Service Market Drivers
2.3.3 Antibody-Drug Conjugation Service Market Challenges
2.3.4 Antibody-Drug Conjugation Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody-Drug Conjugation Service Players by Revenue
3.1.1 Global Top Antibody-Drug Conjugation Service Players by Revenue (2020-2025)
3.1.2 Global Antibody-Drug Conjugation Service Revenue Market Share by Players (2020-2025)
3.2 Global Antibody-Drug Conjugation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody-Drug Conjugation Service Revenue
3.4 Global Antibody-Drug Conjugation Service Market Concentration Ratio
3.4.1 Global Antibody-Drug Conjugation Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody-Drug Conjugation Service Revenue in 2024
3.5 Global Key Players of Antibody-Drug Conjugation Service Head office and Area Served
3.6 Global Key Players of Antibody-Drug Conjugation Service, Product and Application
3.7 Global Key Players of Antibody-Drug Conjugation Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody-Drug Conjugation Service Breakdown Data by Type
4.1 Global Antibody-Drug Conjugation Service Historic Market Size by Type (2020-2025)
4.2 Global Antibody-Drug Conjugation Service Forecasted Market Size by Type (2026-2031)
5 Antibody-Drug Conjugation Service Breakdown Data by Application
5.1 Global Antibody-Drug Conjugation Service Historic Market Size by Application (2020-2025)
5.2 Global Antibody-Drug Conjugation Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody-Drug Conjugation Service Market Size (2020-2031)
6.2 North America Antibody-Drug Conjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody-Drug Conjugation Service Market Size by Country (2020-2025)
6.4 North America Antibody-Drug Conjugation Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody-Drug Conjugation Service Market Size (2020-2031)
7.2 Europe Antibody-Drug Conjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody-Drug Conjugation Service Market Size by Country (2020-2025)
7.4 Europe Antibody-Drug Conjugation Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody-Drug Conjugation Service Market Size (2020-2031)
8.2 Asia-Pacific Antibody-Drug Conjugation Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody-Drug Conjugation Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody-Drug Conjugation Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody-Drug Conjugation Service Market Size (2020-2031)
9.2 Latin America Antibody-Drug Conjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody-Drug Conjugation Service Market Size by Country (2020-2025)
9.4 Latin America Antibody-Drug Conjugation Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody-Drug Conjugation Service Market Size (2020-2031)
10.2 Middle East & Africa Antibody-Drug Conjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody-Drug Conjugation Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody-Drug Conjugation Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BOC Sciences
11.1.1 BOC Sciences Company Details
11.1.2 BOC Sciences Business Overview
11.1.3 BOC Sciences Antibody-Drug Conjugation Service Introduction
11.1.4 BOC Sciences Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.1.5 BOC Sciences Recent Development
11.2 Abzena
11.2.1 Abzena Company Details
11.2.2 Abzena Business Overview
11.2.3 Abzena Antibody-Drug Conjugation Service Introduction
11.2.4 Abzena Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.2.5 Abzena Recent Development
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Details
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Antibody-Drug Conjugation Service Introduction
11.3.4 Creative Biolabs Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.3.5 Creative Biolabs Recent Development
11.4 WuXi XDC
11.4.1 WuXi XDC Company Details
11.4.2 WuXi XDC Business Overview
11.4.3 WuXi XDC Antibody-Drug Conjugation Service Introduction
11.4.4 WuXi XDC Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.4.5 WuXi XDC Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Details
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Antibody-Drug Conjugation Service Introduction
11.5.4 Merck KGaA Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.5.5 Merck KGaA Recent Development
11.6 Piramal
11.6.1 Piramal Company Details
11.6.2 Piramal Business Overview
11.6.3 Piramal Antibody-Drug Conjugation Service Introduction
11.6.4 Piramal Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.6.5 Piramal Recent Development
11.7 Charles River
11.7.1 Charles River Company Details
11.7.2 Charles River Business Overview
11.7.3 Charles River Antibody-Drug Conjugation Service Introduction
11.7.4 Charles River Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.7.5 Charles River Recent Development
11.8 Syngene
11.8.1 Syngene Company Details
11.8.2 Syngene Business Overview
11.8.3 Syngene Antibody-Drug Conjugation Service Introduction
11.8.4 Syngene Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.8.5 Syngene Recent Development
11.9 Novasep
11.9.1 Novasep Company Details
11.9.2 Novasep Business Overview
11.9.3 Novasep Antibody-Drug Conjugation Service Introduction
11.9.4 Novasep Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.9.5 Novasep Recent Development
11.10 Seagen
11.10.1 Seagen Company Details
11.10.2 Seagen Business Overview
11.10.3 Seagen Antibody-Drug Conjugation Service Introduction
11.10.4 Seagen Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.10.5 Seagen Recent Development
11.11 Levena Biopharma
11.11.1 Levena Biopharma Company Details
11.11.2 Levena Biopharma Business Overview
11.11.3 Levena Biopharma Antibody-Drug Conjugation Service Introduction
11.11.4 Levena Biopharma Revenue in Antibody-Drug Conjugation Service Business (2020-2025)
11.11.5 Levena Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Boc Sciences
Abzena
Creative-Biolabs
Merck KGaA
Piramal
Charles River
Syngene
Novasep
Seagen
WuXi XDC
Levena Biopharma
List of Tables
 Table 1. Global Antibody-Drug Conjugation Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antibody Services
 Table 3. Key Players of Payload Services
 Table 4. Key Players of Linker Services
 Table 5. Key Players of Other
 Table 6. Global Antibody-Drug Conjugation Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Antibody-Drug Conjugation Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Antibody-Drug Conjugation Service Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Antibody-Drug Conjugation Service Market Share by Region (2020-2025)
 Table 10. Global Antibody-Drug Conjugation Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Antibody-Drug Conjugation Service Market Share by Region (2026-2031)
 Table 12. Antibody-Drug Conjugation Service Market Trends
 Table 13. Antibody-Drug Conjugation Service Market Drivers
 Table 14. Antibody-Drug Conjugation Service Market Challenges
 Table 15. Antibody-Drug Conjugation Service Market Restraints
 Table 16. Global Antibody-Drug Conjugation Service Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Antibody-Drug Conjugation Service Market Share by Players (2020-2025)
 Table 18. Global Top Antibody-Drug Conjugation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-Drug Conjugation Service as of 2024)
 Table 19. Ranking of Global Top Antibody-Drug Conjugation Service Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Antibody-Drug Conjugation Service Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Antibody-Drug Conjugation Service, Headquarters and Area Served
 Table 22. Global Key Players of Antibody-Drug Conjugation Service, Product and Application
 Table 23. Global Key Players of Antibody-Drug Conjugation Service, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Antibody-Drug Conjugation Service Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Antibody-Drug Conjugation Service Revenue Market Share by Type (2020-2025)
 Table 27. Global Antibody-Drug Conjugation Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Antibody-Drug Conjugation Service Revenue Market Share by Type (2026-2031)
 Table 29. Global Antibody-Drug Conjugation Service Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Antibody-Drug Conjugation Service Revenue Market Share by Application (2020-2025)
 Table 31. Global Antibody-Drug Conjugation Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Antibody-Drug Conjugation Service Revenue Market Share by Application (2026-2031)
 Table 33. North America Antibody-Drug Conjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Antibody-Drug Conjugation Service Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Antibody-Drug Conjugation Service Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Antibody-Drug Conjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Antibody-Drug Conjugation Service Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Antibody-Drug Conjugation Service Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Antibody-Drug Conjugation Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Antibody-Drug Conjugation Service Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Antibody-Drug Conjugation Service Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Antibody-Drug Conjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Antibody-Drug Conjugation Service Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antibody-Drug Conjugation Service Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Antibody-Drug Conjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Antibody-Drug Conjugation Service Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Antibody-Drug Conjugation Service Market Size by Country (2026-2031) & (US$ Million)
 Table 48. BOC Sciences Company Details
 Table 49. BOC Sciences Business Overview
 Table 50. BOC Sciences Antibody-Drug Conjugation Service Product
 Table 51. BOC Sciences Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 52. BOC Sciences Recent Development
 Table 53. Abzena Company Details
 Table 54. Abzena Business Overview
 Table 55. Abzena Antibody-Drug Conjugation Service Product
 Table 56. Abzena Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 57. Abzena Recent Development
 Table 58. Creative Biolabs Company Details
 Table 59. Creative Biolabs Business Overview
 Table 60. Creative Biolabs Antibody-Drug Conjugation Service Product
 Table 61. Creative Biolabs Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 62. Creative Biolabs Recent Development
 Table 63. WuXi XDC Company Details
 Table 64. WuXi XDC Business Overview
 Table 65. WuXi XDC Antibody-Drug Conjugation Service Product
 Table 66. WuXi XDC Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 67. WuXi XDC Recent Development
 Table 68. Merck KGaA Company Details
 Table 69. Merck KGaA Business Overview
 Table 70. Merck KGaA Antibody-Drug Conjugation Service Product
 Table 71. Merck KGaA Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 72. Merck KGaA Recent Development
 Table 73. Piramal Company Details
 Table 74. Piramal Business Overview
 Table 75. Piramal Antibody-Drug Conjugation Service Product
 Table 76. Piramal Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 77. Piramal Recent Development
 Table 78. Charles River Company Details
 Table 79. Charles River Business Overview
 Table 80. Charles River Antibody-Drug Conjugation Service Product
 Table 81. Charles River Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 82. Charles River Recent Development
 Table 83. Syngene Company Details
 Table 84. Syngene Business Overview
 Table 85. Syngene Antibody-Drug Conjugation Service Product
 Table 86. Syngene Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 87. Syngene Recent Development
 Table 88. Novasep Company Details
 Table 89. Novasep Business Overview
 Table 90. Novasep Antibody-Drug Conjugation Service Product
 Table 91. Novasep Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 92. Novasep Recent Development
 Table 93. Seagen Company Details
 Table 94. Seagen Business Overview
 Table 95. Seagen Antibody-Drug Conjugation Service Product
 Table 96. Seagen Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 97. Seagen Recent Development
 Table 98. Levena Biopharma Company Details
 Table 99. Levena Biopharma Business Overview
 Table 100. Levena Biopharma Antibody-Drug Conjugation Service Product
 Table 101. Levena Biopharma Revenue in Antibody-Drug Conjugation Service Business (2020-2025) & (US$ Million)
 Table 102. Levena Biopharma Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Antibody-Drug Conjugation Service Picture
 Figure 2. Global Antibody-Drug Conjugation Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antibody-Drug Conjugation Service Market Share by Type: 2024 VS 2031
 Figure 4. Antibody Services Features
 Figure 5. Payload Services Features
 Figure 6. Linker Services Features
 Figure 7. Other Features
 Figure 8. Global Antibody-Drug Conjugation Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Antibody-Drug Conjugation Service Market Share by Application: 2024 VS 2031
 Figure 10. Breast Cancer Case Studies
 Figure 11. Lymphoma Case Studies
 Figure 12. Other Case Studies
 Figure 13. Antibody-Drug Conjugation Service Report Years Considered
 Figure 14. Global Antibody-Drug Conjugation Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Antibody-Drug Conjugation Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Antibody-Drug Conjugation Service Market Share by Region: 2024 VS 2031
 Figure 17. Global Antibody-Drug Conjugation Service Market Share by Players in 2024
 Figure 18. Global Top Antibody-Drug Conjugation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-Drug Conjugation Service as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Antibody-Drug Conjugation Service Revenue in 2024
 Figure 20. North America Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Antibody-Drug Conjugation Service Market Share by Country (2020-2031)
 Figure 22. United States Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Antibody-Drug Conjugation Service Market Share by Country (2020-2031)
 Figure 26. Germany Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Antibody-Drug Conjugation Service Market Share by Region (2020-2031)
 Figure 34. China Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Antibody-Drug Conjugation Service Market Share by Country (2020-2031)
 Figure 42. Mexico Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Antibody-Drug Conjugation Service Market Share by Country (2020-2031)
 Figure 46. Turkey Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Antibody-Drug Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. BOC Sciences Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 50. Abzena Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 51. Creative Biolabs Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 52. WuXi XDC Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 53. Merck KGaA Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 54. Piramal Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 55. Charles River Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 56. Syngene Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 57. Novasep Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 58. Seagen Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 59. Levena Biopharma Revenue Growth Rate in Antibody-Drug Conjugation Service Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Antibody Drug Conjugate Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antibody Drug Conjugate Linker And Conjugation Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peptide Drug Conjugates Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antibody Drug Conjugate ADC Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Monoclonal Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Next Generation Antibody Drug Market Research Report 2024
Global BioPharma Service Market Research Report 2024
Drug Analysis Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
New Drug Research and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medicine Transportation Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacokinetics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharmaceutical Development Support Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacogenomics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune Drugs Market Insights Forecast to 2030
Global Pharma Contract Service Market Research Report 2025
Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Reference App Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Discovery Screening Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Screening Laboratory Service Market

RELATED REPORTS

Global Failure Analysis and Investigation Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25S19602
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Mine Schedule Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14P19942
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Mine Survey Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1N19842
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Cotton ERP System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6T20027
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions